• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Class 2 Device Recall Autostainer Link 48, Autostainer Plus, Autostainer, and Autostainer Link Instrument

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
  Class 2 Device Recall Autostainer Link 48, Autostainer Plus, Autostainer, and Autostainer Link Instrument see related information
Date Initiated by Firm February 12, 2015
Date Posted March 16, 2015
Recall Status1 Terminated 3 on February 11, 2016
Recall Number Z-1261-2015
Recall Event ID 70558
Product Classification Slide stainer, automated - Product Code KPA
Product Autostainer Link 48 (AS480), Autostainer Plus Link Instrument (AS100), Autostainer (S3400), and Autostainer Plus (S3800). Automated slide stainer for in vitro diagnostic use.
Code Information 992640 Rev. 02, 992085 Rev.no H, 992625 Rev.no F, 992326 Rev.no C  Affected dates: 12/2013-08/2014  Each device is labeled with a unique serial number.  Catalog/Model Number: - AS480 - S3800 - S3400 - AS100
Recalling Firm/
Manufacturer
Dako North America Inc.
6392 Via Real
Carpinteria CA 93013-2921
For Additional Information Contact
805-566-6655
Manufacturer Reason
for Recall
A false negative result affecting the diagnosis may occur. A defect in the syringe assembly stopcock component may, in some circumstances, cause leakage of excess buffer onto slide location 34 on the AS480, or slide locations 35 and 36 on the AS100, S3400, and S3800. Affected dates are from 12/2013-08/2014.
FDA Determined
Cause 2
Nonconforming Material/Component
Action The firm, Dako, sent an "Urgent Medical Device Recall Notification" letter dated 2/12/15 to customer on 02/12/15. The firm's letter advised customers to do the following: The firm stated that customers can continue to use the instrument however should take the following actions: - Discontinue to use the HercepTest on slide location 34 - As set forth in Dako's staining protocol, use on-slide positive controls and two drop zones - Watch for any indication of buffer leakage from they syringe assembly. This can be done easily when the tubes are checked for air bubbles in connection with exchange of the buffer bottle - Check for weak staining in regards to HercepTest in slide position 34. Dako's Actions: Dako states that a representative will contact the customers within the next few weeks in order to determine whether the HercepTest has been used for staining slides in position 34. The firm has identified a longer term corrective action plan of installing a drip tray under the stopcock and states that a representative will contact the customer when it is available. Transmission of Notice: The firm requests that customers inform those that need to be aware of the notification and to where the instruments might have been transferred to. The firm states that customers should ensure the organizations maintains awareness of the noticed and recommended steps until the corrective actions have been completed. The firm also asks customers to complete, sign, and return the attached recall form as soon as possible. On 02/23/15 the firm sent out a second notification letter to customers with the following additional recommendations: - Discontinue the use of HercepTest in slide location 34, 35, and 36 depending on the make and model of the instrument In addition the firm recommended that customers pay special attention to any indication that leakage has compromised staining. -When staining using the HercepTest protocols, excess leakage from the sy
Quantity in Commerce 409
Distribution Worldwide Distribution: US (nationwide) and countries of: AT, AU, BE, CA, CH, DE, DK, ES, FR, GB, IE, IT, JP, NL, NO, PL, and SE.
Total Product Life Cycle TPLC Device Report

1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
-
-